The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | The limitations of CAR-T currently: overcoming resistance
Loretta Nastoupil
• 2 Apr 2019
Loretta Nastoupil, MD, MD Anderson Cancer Center, Houston, TX, discusses the limitations of CAR-T currently, focusing on resistance and explaining some of the approaches that are aiming to overcome this. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.
